Medical Cannabis Out of Stock in Switzerland: What to Do Next

Your prescribed cannabis medicine is unavailable? Prepare questions about supply, a possible medicine change, prescriptions and costs for your Swiss pharmacy.

You have a prescription, but the pharmacy cannot supply your usual cannabis medicine. What you need now is a clear next step: exactly what is unavailable, who can assess an alternative, and what happens if your remaining supply runs out first? This guide helps you prepare the conversation with your pharmacy and treating team. It does not describe a current nationwide shortage or confirm any supplier’s stock.

What exactly is unavailable?

‘Cannabis is unavailable’ is not specific enough. Ask for the preparation’s full name, concentration, dosage form and pack size. If a pack is simply missing from the pharmacy’s shelves, it may be possible to order it. If the relevant supplier cannot provide it, the position may be different. Ask what has actually been checked and what is still unknown.

A delivery date can be confirmed, provisional or unknown. Record that distinction: ‘probably next week’ is not a guarantee. A product appearing in an online shop does not establish that your exact prescribed medicine can be dispensed either. If a recall or quality issue is mentioned, ask about it separately; that is different from a simple lack of stock.

Also check how much you have left, using the unit on the packaging and describing your actual use. Do not turn an uncertain remaining quantity into an apparently precise number of treatment days. The purpose is to help the professionals assess how time-sensitive the situation is.

Your pharmacy and treating team: who handles the next step?

The dispensing pharmacy is the first contact for stock, ordering options and existing dispensing documents. Ask whether it can contact the prescribing practice and what information is missing. If another pharmacy is being considered, check before travelling whether the exact preparation is available and which prescription and previous-dispensing records are needed.

Your treating team needs to know if the prescribed treatment is unlikely to continue as planned. This is more than a shopping question. Explain when your remaining supply is likely to run out, which symptoms are being treated and whether a change has already been discussed. If a specialist service manages the treatment, include it in that coordination.

Agree who will contact whom, when to expect a response and what to do if there is no solution by then. An informal availability enquiry elsewhere does not replace that coordination. This article promises neither immediate replacement dispensing nor a fixed processing time.

Distinguishing preparations and medical access in Switzerland

Why a different preparation is not simply the same medicine

A strain name or similar THC figure does not establish that two medicines are interchangeable. Relevant details include the specific preparation, THC and CBD content with their units, the dosage form and intended use. An authorised ready-to-use medicine and an individually compounded preparation also have different regulatory statuses.

One oil may state its concentration per millilitre, while another product presents its information differently. A drop is not a uniform quantity across products either. Do not independently carry over the number of drops, grams or frequency of use to an alternative. Moving from flowers to an oil is more than a change of packaging.

If a change is agreed, ask your treating team for an unambiguous plan for the exact new preparation. Leave unknown details unresolved rather than filling them in from advertising. Mention other medicines and new symptoms too. The decision needs to fit the treatment; a lower price or similar description is not enough.

Considering other medicines and possible interactions

Clarify the prescription, documents and costs before dispensing

The responsible pharmacy or prescribing professional must check whether the existing prescription is sufficient for the proposed next step. Ask specifically whether clarification, a new prescription or other documents are needed. A supply problem does not automatically dictate a single prescription process or authorise dispensing any substitute product.

Previous collections and dispensing records may matter to another pharmacy. Coordinate further supply instead of placing several orders in parallel. Send prescriptions and health information through the channel specified by the practice or pharmacy; publicly shared photographs and community posts are not suitable.

Ask for the total price of the proposed preparation and any additional services that apply. If you have an insurer’s cost approval, check whether it covers the new situation. Previous reimbursement is not blanket approval for every other product. Unknown costs belong on the list of questions to resolve, rather than being counted as assumed savings.

If an interruption is likely, agree an individual plan

Make contact before the pack runs out where possible. Ask what to do while awaiting a response or the next treatment step, and whom to contact outside normal opening hours. This is particularly important if the condition being treated could worsen. Acute severe symptoms require prompt medical help rather than waiting for an ordinary response to an order.

Do not change prescribed treatment on your own to make the remaining amount last longer. Other medicines should not be increased or changed independently to compensate either. A general online article cannot determine whether a pause, an adjustment or a different treatment is appropriate for you.

Freely sold CBD, cannabis obtained through a community or products from a pilot trial are not automatically suitable ways to bridge a medical treatment interruption. A club account does not confer entitlement to a medicine. For overseas offers, do not assume that a Swiss prescription permits every shipment or border crossing. Clarify lawful supply routes with the responsible professionals.

Club membership and medical treatment are separate routes

A checklist for the conversation

A few organised details make an enquiry more actionable than ‘my medicine is missing’. Have the current packaging, or legible information from it, and your medication list ready. Mark unknown items as unknown; an initial message does not need to contain your entire medical record.

This checklist prepares a conversation; it does not select a replacement medicine. The example message deliberately contains no dosing instruction. Fill in only information you know and use the agreed contact channel.

• Full preparation name, dosage form and packaging information
• THC and CBD content with the printed units
• Remaining amount and actual use so far
• Date and exact content of the availability response
• Current other medicines and relevant new symptoms
• Prescription, previous collections and any insurer cost approval
• Next contact, responsible person and agreed response time

A short message to start the conversation

According to the response received on [date], my prescribed preparation [name, form, concentration] is currently unavailable. I have [known amount] left. Please help me clarify how treatment should continue, whether further documents are needed and when I should expect a response. I can send my current use and medication list through the agreed channel.

Recording use and observations in a cannabis diary

After an agreed change, keep observations traceable

If the treating team agrees a change, keep the current plan alongside the new packaging information. Record when you actually started using each preparation. This helps avoid later confusion between an old prescription, a product merely suggested and what you really used.

Note new symptoms or unwanted effects with their timing and context. A sequence in time does not prove causation, but it provides useful information to discuss. Clarify when to report back and which observations require earlier contact. A successful delivery alone does not establish that the new treatment plan suits you.

Position as of 15 October 2026. General preparation for conversations in Switzerland, not individual treatment or dosing instructions. Availability, dispensing and reimbursement require checking for the specific medicine.